Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 1 → 2·08:27, 13 Jun 2025
Difference between revision 1 and revision 2 of Qingdao Saber Technology Pharmaceutical. 3 lines changed; the page grew by 360 bytes.
| Revision 1 — 09:00, 11 Jun 2025 GroupBuyGalen (talk) create organisation article per PP:VN 1,758 bytes +1,758 | Revision 2 — 08:27, 13 Jun 2025 TirzTaxonomist (talk) sentence case in headings per PP:MOS 2,118 bytes +360 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | == Corporate identity and history == | |
| + | 13 | Incorporated in 2017 in Qingdao, the organisation is one of two covered here based in that city, the other being Qingdao Sigma Chemical.{{r|registry}} Qingdao has a substantial chemical and pharmaceutical-intermediate sector and a major port, which is the extent of what can reliably be said about the industrial context. | |
| + | 14 | ||
| 12 | == References == | 15 | == References == |
| 13 | {{reflist}} | 16 | {{reflist}} |